e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Diffuse parenchymal lung disease II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution
H. Novais e Bastos, P. Mota, N. Melo, M. Beltrão, O. Sokhatska, C. Palmares, A. Morais (Porto, Braga, Portugal)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease II
Session:
Diffuse parenchymal lung disease II
Session type:
Thematic Poster Session
Number:
3649
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Novais e Bastos, P. Mota, N. Melo, M. Beltrão, O. Sokhatska, C. Palmares, A. Morais (Porto, Braga, Portugal). Pulmonary eosinophilic syndromes characterization. The role of peripheral eosinophilia as a marker of clinical evolution. Eur Respir J 2012; 40: Suppl. 56, 3649
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Distinct clinical and pathological phenotypes in IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
The role of systemic markers of inflammation in bronchiectasis.
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
The importance of inflammatory markers in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Differential diagnosis of pulmonary eosinophilia
Source: Eur Respir Monogr 2022; 95: 19-36
Year: 2022
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012
Frequencies and dynamics of peripheral immune cell subsets in idiopathic pulmonary fibrosis: Preliminary results and clinical implications
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007
Peripheral blood eosinophilia and clinical phenotype in Bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment
Source: Virtual Congress 2020 – When the lung gets stiff
Year: 2020
Comprehensive evaluation of airway involvement in pulmonary sarcoidosis
Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016
Year: 2017
Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept